Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for August 2015

    ... non-myeloablative conditioning and post transplantation cyclophosphamide with partially HLA -mismatched donors. This ...

    Page last updated 07/30/2015 - 8:45am.

  2. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... Associated Drug(s):  Cyclophosphamide Phase:  ... Procedure: Unmanipulated Bone Marrow Graft with Cyclophosphamide Unmanipulated BM grafts will be administered on Day 0 to ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.

  3. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... Associated Drug(s):  Cyclophosphamide Mycophenolate Mofetil ... FK506 Drug: Tacrolimus (ARM with MMF and Cyclophosphamide) Tacrolimus will be given orally at a dose of 0.05 mg/kg ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  4. Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... stem cell transplantation HSC HSCT Drug: Cyclophosphamide Given IV Other Names: (-)-Cyclophosphamide 2H-1,3,2-Oxazaphosphorine, ...

    Clinical Trial last updated 04/28/2016 - 1:52pm.

  5. Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia

    ... Antithymocyte Globulin Cyclophosphamide Fludarabine ... to -2 from transplant. Other Name: Fludara Drug: Cyclophosphamide Cyclophosphamide 50 mg/kg IV over 2 hours on day -7 from ...

    Clinical Trial last updated 04/25/2016 - 10:59am.

  6. Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... Marrow Transplant Marrow Transplantation Drug: Cyclophosphamide Given IV Other Names: (-)-Cyclophosphamide 2H-1,3,2-Oxazaphosphorine, ...

    Clinical Trial last updated 04/29/2016 - 12:58pm.

  7. Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... Intervention:  Drug: Cyclophosphamide Given IV Other Names: (-)-Cyclophosphamide 2H-1,3,2-Oxazaphosphorine, ...

    Clinical Trial last updated 04/27/2016 - 1:17pm.

  8. Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

    ... Associated Drug(s):  Cyclophosphamide Phase:  ... x 4 days Other Name: Total Body Irradiation Drug: Cyclophosphamide Cyclophosphamide 60 mg/kg IV daily x 2 consecutive days ...

    Clinical Trial last updated 04/29/2016 - 10:59am.

  9. Selective Depletion of CD45RA+ Naive T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... cell transplantation HSC HSCT Drug: Cyclophosphamide Given IV Other Names: ...

    Clinical Trial last updated 06/06/2016 - 2:55pm.

  10. Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    ... Associated Drug(s):  Cyclophosphamide Phase:  ... with a maximum of 3 mCi On day + 28 (+/- 5 days) Drug: Cyclophosphamide Cyclophosphamide: 60 mg/kg IV on days -4 and -3 (for Adults & ...

    Clinical Trial last updated 04/28/2016 - 11:14am.